As of Nov. 9, 13 Tamiflu generics were in short supply among six drugmakers, according to the drug shortage website run by the American Society of Health-System Pharmacists. The antibiotics amoxicillin and Augmentin are also in short supply, along with inhalers for the drug albuterol, which helps open airways in the lungs.
Michael Ganio, ASHO’s senior director of pharmacy practice and quality, said manufacturing issues are not to blame for the shortages.
“It’s just increased demand ahead of schedule and higher than usual,” he told CNN.
Many generic drugmakers are increasing production in response to heightened demand. Teva said it expects some concentrations of amoxicillin to be back in stock between early December and late February. Roche told Becker’s it has “sufficient supply” of Tamiflu and encouraged pharmacies to stock up enough product throughout flu season.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
